Literature DB >> 11176083

Assessment of depth of anesthesia and postoperative respiratory recovery after remifentanil- versus alfentanil-based total intravenous anesthesia in patients undergoing ear-nose-throat surgery.

R Wuesten1, H Van Aken, P S Glass, H Buerkle.   

Abstract

BACKGROUND: The authors investigated whether total intravenous anesthesia (TIVA) with precalculated equipotent infusion schemes for remifentanil and alfentanil would ensure appropriate analgesia and that remifentanil would result in better recovery characteristics.
METHODS: Forty consenting patients (classified as American Society of Anesthesiologists physical status I-III) scheduled for microlaryngoscopy were randomized to receive, in a double-blind manner, either remifentanil (loading dose 1 microg/kg; maintenance infusion, 0.25 microg x kg(-1) x min-1) or alfentanil (loading dose, 50 microg/kg; maintenance infusion, 1 microg x kg(-1) x min-1) as the analgesic component of TIVA. They were combined with propofol (loading dose, 2 mg/kg; maintenance infusion, 100 microg x kg(-1) min(-1)). To insure an equal state of anesthesia, the opioids were titrated to maintain heart rate and mean arterial pressure within 20% of baseline, and propofol was titrated to keep the bispectral index (BIS) less than 60. Neuromuscular blockade was achieved with succinylcholine. Drug dosages and the times from cessation of anesthesia to extubation, verbal response, recovery of ventilation, and neuropsychological testing, orientation, and discharge readiness were recorded.
RESULTS: Demographics, duration of surgery, and anesthesia were similar between the two groups. Both groups received similar propofol doses. There were no difference in BIS values preoperatively (mean, 96), intraoperatively (mean, 55), and postoperatively (mean, 96). Recovery of BIS and times for verbal response did not differ. At 20, 30, and 40 min after terminating the opioid infusion, the peripheral oxygen saturation and respiratory rate were significantly higher in the remifentanil group compared with the alfentanil group.
CONCLUSIONS: When both the hypnotic and analgesic components of a TIVA-based anesthetic are administered in equipotent doses, remifentanil provides a more rapid respiratory recovery, even after brief surgical procedures, compared with alfentanil.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11176083     DOI: 10.1097/00000542-200102000-00008

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

Review 1.  General anesthesia and altered states of arousal: a systems neuroscience analysis.

Authors:  Emery N Brown; Patrick L Purdon; Christa J Van Dort
Journal:  Annu Rev Neurosci       Date:  2011       Impact factor: 12.449

2.  Remifentanil versus fentanyl compared in a target-controlled infusion of propofol anesthesia: quality of anesthesia and recovery profile.

Authors:  Demet Coskun; Hulya Celebi; Gozde Karaca; Lale Karabiyik
Journal:  J Anesth       Date:  2010-03-13       Impact factor: 2.078

3.  Suxamethonium induces a prompt increase in the bispectral index.

Authors:  Jong Bum Choi; Se Hee Na; Sook Young Lee; Jong Yeop Kim; Sung Yong Park; Ji Eun Kim; Seungbae Hong; Jiwon An; Chung Hoon Park; Yong Chan Kim; Woo Young Park
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

4.  Impact of short-acting vs. standard anaesthetic agents on obstructive sleep apnoea: a randomised, controlled, triple-blind trial.

Authors:  E Albrecht; V Bayon; C Hirotsu; R Heinzer
Journal:  Anaesthesia       Date:  2020-08-17       Impact factor: 6.955

5.  The comparison of Alfentanil and Remifentanil infusion during anesthesia on post-anesthesia recovery.

Authors:  Masood Entezariasl; Godrat Akhavanakbari; Khatereh Isazadehfar
Journal:  Saudi J Anaesth       Date:  2012 Oct-Dec

6.  Effect of sevoflurane versus propofol-based anesthesia on the hemodynamic response and recovery characteristics in patients undergoing microlaryngeal surgery.

Authors:  Neerja Bharti; Promila Chari; Parag Kumar
Journal:  Saudi J Anaesth       Date:  2012 Oct-Dec
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.